CN Stock MarketDetailed Quotes

300841 Chengdu Kanghua Biological Products

Watchlist
  • 49.86
  • -0.21-0.42%
Trading Jul 30 11:13 CST
6.71BMarket Cap12.13P/E (TTM)

Chengdu Kanghua Biological Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
11.96%311.37M
9.03%1.58B
-6.12%990.06M
-3.84%634.44M
4.27%278.11M
11.94%1.45B
35.23%1.05B
19.53%659.77M
12.48%266.74M
24.44%1.29B
Operating revenue
11.96%311.37M
9.03%1.58B
-6.12%990.06M
-3.84%634.44M
4.27%278.11M
11.94%1.45B
35.23%1.05B
19.53%659.77M
12.48%266.74M
24.44%1.29B
Other operating revenue
----
-99.11%2.84K
----
--2.84K
----
--318.58K
----
--0
----
--0
Total operating cost
-19.05%134.86M
22.80%959.26M
15.87%586.25M
22.16%363.21M
38.63%166.6M
20.72%781.12M
38.27%505.94M
14.61%297.32M
2.99%120.17M
15.41%647.05M
Operating cost
-27.99%12.93M
9.68%102.15M
-4.57%63.76M
2.43%41.12M
15.80%17.96M
11.21%93.13M
30.08%66.82M
14.12%40.14M
-1.88%15.51M
33.27%83.75M
Operating tax surcharges
26.47%1.43M
18.61%9.76M
2.94%5.9M
9.20%4.48M
0.94%1.13M
15.33%8.23M
39.12%5.73M
28.05%4.1M
17.52%1.12M
6.54%7.14M
Operating expense
-8.28%71.89M
15.73%495.44M
4.95%270.26M
14.18%175.11M
14.13%78.39M
3.89%428.12M
18.06%257.51M
-0.83%153.37M
6.21%68.68M
11.06%412.07M
Administration expense
12.59%24.97M
29.22%106.82M
14.31%66.26M
2.19%40.46M
15.89%22.18M
-4.27%82.66M
-7.83%57.96M
-9.85%39.6M
-20.26%19.14M
16.79%86.35M
Financial expense
-28.00%-2.2M
27.55%-7.95M
40.27%-5.86M
53.37%-3.77M
67.47%-1.72M
48.11%-10.97M
39.97%-9.82M
32.38%-8.08M
3.68%-5.29M
-73.98%-21.14M
-Interest expense (Financial expense)
37.51%1.41M
50.71%4.81M
76.90%3.54M
184.89%2.36M
1,441.19%1.02M
4,286.84%3.19M
3,316.43%2M
1,816.19%826.91K
--66.49K
-68.50%72.69K
-Interest Income (Financial expense)
-24.89%-3.46M
11.68%-12.59M
22.04%-9.24M
34.03%-5.93M
48.46%-2.77M
33.01%-14.26M
28.01%-11.86M
25.34%-9M
2.31%-5.37M
-70.79%-21.28M
Research and development
-46.92%25.83M
40.62%253.03M
45.56%185.93M
55.17%105.81M
131.58%48.66M
128.13%179.94M
179.06%127.73M
98.05%68.19M
25.42%21.01M
35.40%78.88M
Credit Impairment Loss
26.98%-5.56M
72.19%-9.84M
63.68%-7.28M
44.77%-10.16M
-116.24%-7.61M
-317.30%-35.37M
-218.59%-20.03M
-363.16%-18.39M
-25.83%-3.52M
-9,569.89%-8.48M
Asset Impairment Loss
151.32%94.42K
81.27%-1.63M
236.90%1.29M
46.41%-465.23K
71.78%-183.96K
-345.37%-8.71M
-3.45%-944.55K
-46.55%-868.06K
-182.28%-651.8K
-5,786.52%-1.95M
Other net revenue
-178.90%-4.36M
-308.64%-41.52M
102.28%4.72M
948.03%6.9M
-42.30%5.52M
-92.64%19.9M
-99.02%2.33M
-113.25%-813.22K
740.54%9.57M
3,733.24%270.36M
Fair value change income
-96.00%521.7K
-160.89%-31.6M
-6.44%10.94M
62.00%15.44M
4.10%13.05M
-80.73%51.89M
-95.09%11.7M
24.75%9.53M
--12.54M
--269.32M
Invest income
--91.66K
-93.04%348.75K
----
----
----
7.68%5.01M
23.35%5.01M
77.93%5.01M
----
109.27%4.65M
Asset deal income
----
---186.83K
----
----
----
----
----
----
----
----
Other revenue
88.31%491.51K
-80.51%1.38M
-103.70%-244.09K
-46.85%2.08M
-78.27%261.01K
3.91%7.08M
248.06%6.6M
1,487.07%3.91M
967.30%1.2M
36.75%6.81M
Operating profit
47.09%172.15M
-15.88%576.61M
-25.85%408.53M
-23.09%278.12M
-25.04%117.04M
-25.14%685.5M
-15.36%550.94M
21.07%361.64M
31.24%156.13M
88.79%915.76M
Add:Non operating Income
----
-87.34%15.5K
-63.85%44.07K
208.45%15.43K
729,894.63%10.88K
-70.91%122.45K
-71.04%121.92K
109.06%5K
-99.94%1.49
7,805.84%420.99K
Less:Non operating expense
-93.32%10.68K
43.83%2.63M
-54.49%539.07K
-78.56%242.03K
98,293.32%159.84K
205.41%1.83M
106.53%1.18M
134.82%1.13M
-97.48%162.45
-46.77%599.64K
Total profit
47.27%172.14M
-16.06%573.99M
-25.80%408.03M
-22.92%277.9M
-25.14%116.89M
-25.32%683.79M
-15.50%549.87M
20.89%360.52M
31.25%156.13M
89.19%915.58M
Less:Income tax cost
93.85%22.68M
-24.44%64.78M
-41.27%39.09M
-33.79%29.69M
-43.91%11.7M
-0.43%85.73M
-1.24%66.56M
-2.63%44.84M
12.96%20.86M
13.45%86.1M
Net profit
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
103.28%829.48M
Net profit from continuing operation
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
----
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
----
34.60%135.28M
103.28%829.48M
Net profit of parent company owners
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
103.28%829.48M
Earning per share
Basic earning per share
42.45%1.1204
-14.73%3.8073
-23.52%2.7584
-21.17%1.8558
-21.94%0.7865
-27.56%4.4652
-16.79%3.6067
25.65%2.3542
-9.77%1.0076
18.96%6.1638
Diluted earning per share
42.49%1.1204
-14.71%3.8073
-23.53%2.758
-21.19%1.8554
-21.96%0.7863
-27.57%4.464
-16.79%3.6067
25.65%2.3542
-9.78%1.0075
18.94%6.163
Other composite income
Total composite income
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
103.28%829.48M
Total composite income of parent company owners
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
103.28%829.48M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 11.96%311.37M9.03%1.58B-6.12%990.06M-3.84%634.44M4.27%278.11M11.94%1.45B35.23%1.05B19.53%659.77M12.48%266.74M24.44%1.29B
Operating revenue 11.96%311.37M9.03%1.58B-6.12%990.06M-3.84%634.44M4.27%278.11M11.94%1.45B35.23%1.05B19.53%659.77M12.48%266.74M24.44%1.29B
Other operating revenue -----99.11%2.84K------2.84K------318.58K------0------0
Total operating cost -19.05%134.86M22.80%959.26M15.87%586.25M22.16%363.21M38.63%166.6M20.72%781.12M38.27%505.94M14.61%297.32M2.99%120.17M15.41%647.05M
Operating cost -27.99%12.93M9.68%102.15M-4.57%63.76M2.43%41.12M15.80%17.96M11.21%93.13M30.08%66.82M14.12%40.14M-1.88%15.51M33.27%83.75M
Operating tax surcharges 26.47%1.43M18.61%9.76M2.94%5.9M9.20%4.48M0.94%1.13M15.33%8.23M39.12%5.73M28.05%4.1M17.52%1.12M6.54%7.14M
Operating expense -8.28%71.89M15.73%495.44M4.95%270.26M14.18%175.11M14.13%78.39M3.89%428.12M18.06%257.51M-0.83%153.37M6.21%68.68M11.06%412.07M
Administration expense 12.59%24.97M29.22%106.82M14.31%66.26M2.19%40.46M15.89%22.18M-4.27%82.66M-7.83%57.96M-9.85%39.6M-20.26%19.14M16.79%86.35M
Financial expense -28.00%-2.2M27.55%-7.95M40.27%-5.86M53.37%-3.77M67.47%-1.72M48.11%-10.97M39.97%-9.82M32.38%-8.08M3.68%-5.29M-73.98%-21.14M
-Interest expense (Financial expense) 37.51%1.41M50.71%4.81M76.90%3.54M184.89%2.36M1,441.19%1.02M4,286.84%3.19M3,316.43%2M1,816.19%826.91K--66.49K-68.50%72.69K
-Interest Income (Financial expense) -24.89%-3.46M11.68%-12.59M22.04%-9.24M34.03%-5.93M48.46%-2.77M33.01%-14.26M28.01%-11.86M25.34%-9M2.31%-5.37M-70.79%-21.28M
Research and development -46.92%25.83M40.62%253.03M45.56%185.93M55.17%105.81M131.58%48.66M128.13%179.94M179.06%127.73M98.05%68.19M25.42%21.01M35.40%78.88M
Credit Impairment Loss 26.98%-5.56M72.19%-9.84M63.68%-7.28M44.77%-10.16M-116.24%-7.61M-317.30%-35.37M-218.59%-20.03M-363.16%-18.39M-25.83%-3.52M-9,569.89%-8.48M
Asset Impairment Loss 151.32%94.42K81.27%-1.63M236.90%1.29M46.41%-465.23K71.78%-183.96K-345.37%-8.71M-3.45%-944.55K-46.55%-868.06K-182.28%-651.8K-5,786.52%-1.95M
Other net revenue -178.90%-4.36M-308.64%-41.52M102.28%4.72M948.03%6.9M-42.30%5.52M-92.64%19.9M-99.02%2.33M-113.25%-813.22K740.54%9.57M3,733.24%270.36M
Fair value change income -96.00%521.7K-160.89%-31.6M-6.44%10.94M62.00%15.44M4.10%13.05M-80.73%51.89M-95.09%11.7M24.75%9.53M--12.54M--269.32M
Invest income --91.66K-93.04%348.75K------------7.68%5.01M23.35%5.01M77.93%5.01M----109.27%4.65M
Asset deal income -------186.83K--------------------------------
Other revenue 88.31%491.51K-80.51%1.38M-103.70%-244.09K-46.85%2.08M-78.27%261.01K3.91%7.08M248.06%6.6M1,487.07%3.91M967.30%1.2M36.75%6.81M
Operating profit 47.09%172.15M-15.88%576.61M-25.85%408.53M-23.09%278.12M-25.04%117.04M-25.14%685.5M-15.36%550.94M21.07%361.64M31.24%156.13M88.79%915.76M
Add:Non operating Income -----87.34%15.5K-63.85%44.07K208.45%15.43K729,894.63%10.88K-70.91%122.45K-71.04%121.92K109.06%5K-99.94%1.497,805.84%420.99K
Less:Non operating expense -93.32%10.68K43.83%2.63M-54.49%539.07K-78.56%242.03K98,293.32%159.84K205.41%1.83M106.53%1.18M134.82%1.13M-97.48%162.45-46.77%599.64K
Total profit 47.27%172.14M-16.06%573.99M-25.80%408.03M-22.92%277.9M-25.14%116.89M-25.32%683.79M-15.50%549.87M20.89%360.52M31.25%156.13M89.19%915.58M
Less:Income tax cost 93.85%22.68M-24.44%64.78M-41.27%39.09M-33.79%29.69M-43.91%11.7M-0.43%85.73M-1.24%66.56M-2.63%44.84M12.96%20.86M13.45%86.1M
Net profit 42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M103.28%829.48M
Net profit from continuing operation 42.09%149.47M-14.86%509.22M-23.66%368.94M-----22.24%105.19M-27.90%598.07M-17.15%483.31M----34.60%135.28M103.28%829.48M
Net profit of parent company owners 42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M103.28%829.48M
Earning per share
Basic earning per share 42.45%1.1204-14.73%3.8073-23.52%2.7584-21.17%1.8558-21.94%0.7865-27.56%4.4652-16.79%3.606725.65%2.3542-9.77%1.007618.96%6.1638
Diluted earning per share 42.49%1.1204-14.71%3.8073-23.53%2.758-21.19%1.8554-21.96%0.7863-27.57%4.464-16.79%3.606725.65%2.3542-9.78%1.007518.94%6.163
Other composite income
Total composite income 42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M103.28%829.48M
Total composite income of parent company owners 42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M103.28%829.48M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg